XML 177 R54.htm IDEA: XBRL DOCUMENT v3.25.1
Long-Term Investments - Schedule of Balance Sheets (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
BioFirst [Member]    
Schedule of Balance Sheet [Line Items]    
Current Assets $ 1,323,952 $ 1,451,877
Non-current Assets 1,083,472 686,206
Current Liabilities 3,508,413 2,286,058
Non-current Liabilities 114,606 347,193
Shareholders’ Deficit (1,215,595) (495,168)
Rgene [Member]    
Schedule of Balance Sheet [Line Items]    
Current Assets 46,491 50,538
Non-current Assets 222,988 250,716
Current Liabilities 1,546,123 2,591,960
Non-current Liabilities 319 811
Shareholders’ Deficit $ (1,276,963) $ (2,291,517)